Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huang Tan

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Breast Cancer Research and Treatment|December 20, 2021
Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancerKritika Yadav, Joline Lim, Joan Choo, et al.
Scientific Reports|July 20, 2019
Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular CarcinomaYu Jin, Ye Shen Wong, Brian K P Goh, et al.
Oncotarget|September 1, 2016
Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancerAndrea L A Wong, Raghav Sundar, Ting-Ting Wang, et al.
Acta Neuropathologica|October 11, 2024
Neuronal BAG3 attenuates tau hyperphosphorylation, synaptic dysfunction, and cognitive deficits induced by traumatic brain injury via the regulation of autophagy-lysosome pathwayNicholas Sweeney, Tae Yeon Kim, Cody T Morrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2020
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive CancersSoo-Chin Lee, Noriko Shimasaki, Joline S J Lim, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Breast Cancer Research and Treatment|December 20, 2021
Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancerKritika Yadav, Joline Lim, Joan Choo, et al.
Scientific Reports|July 20, 2019
Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular CarcinomaYu Jin, Ye Shen Wong, Brian K P Goh, et al.
Oncotarget|September 1, 2016
Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancerAndrea L A Wong, Raghav Sundar, Ting-Ting Wang, et al.
Acta Neuropathologica|October 11, 2024
Neuronal BAG3 attenuates tau hyperphosphorylation, synaptic dysfunction, and cognitive deficits induced by traumatic brain injury via the regulation of autophagy-lysosome pathwayNicholas Sweeney, Tae Yeon Kim, Cody T Morrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2020
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive CancersSoo-Chin Lee, Noriko Shimasaki, Joline S J Lim, et al.
Pageof 8